1. Home
  2. AQST vs MYN Comparison

AQST vs MYN Comparison

Compare AQST & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • MYN
  • Stock Information
  • Founded
  • AQST 2004
  • MYN 1992
  • Country
  • AQST United States
  • MYN United States
  • Employees
  • AQST N/A
  • MYN N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • MYN Finance Companies
  • Sector
  • AQST Health Care
  • MYN Finance
  • Exchange
  • AQST Nasdaq
  • MYN Nasdaq
  • Market Cap
  • AQST 502.6M
  • MYN 411.5M
  • IPO Year
  • AQST 2018
  • MYN N/A
  • Fundamental
  • Price
  • AQST $4.41
  • MYN $10.34
  • Analyst Decision
  • AQST Strong Buy
  • MYN
  • Analyst Count
  • AQST 7
  • MYN 0
  • Target Price
  • AQST $9.43
  • MYN N/A
  • AVG Volume (30 Days)
  • AQST 1.7M
  • MYN 86.0K
  • Earning Date
  • AQST 11-04-2024
  • MYN 01-01-0001
  • Dividend Yield
  • AQST N/A
  • MYN 4.12%
  • EPS Growth
  • AQST N/A
  • MYN N/A
  • EPS
  • AQST N/A
  • MYN N/A
  • Revenue
  • AQST $58,900,000.00
  • MYN N/A
  • Revenue This Year
  • AQST $18.45
  • MYN N/A
  • Revenue Next Year
  • AQST N/A
  • MYN N/A
  • P/E Ratio
  • AQST N/A
  • MYN N/A
  • Revenue Growth
  • AQST 22.56
  • MYN N/A
  • 52 Week Low
  • AQST $1.69
  • MYN $8.47
  • 52 Week High
  • AQST $6.23
  • MYN $10.62
  • Technical
  • Relative Strength Index (RSI)
  • AQST 37.69
  • MYN 45.08
  • Support Level
  • AQST $4.62
  • MYN $10.25
  • Resistance Level
  • AQST $5.59
  • MYN $10.43
  • Average True Range (ATR)
  • AQST 0.37
  • MYN 0.10
  • MACD
  • AQST -0.11
  • MYN 0.02
  • Stochastic Oscillator
  • AQST 2.54
  • MYN 53.03

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock

Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests primarily in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.

Share on Social Networks: